51 related articles for article (PubMed ID: 38492358)
41. Effect of miR-21 on Renal Fibrosis Induced by Nano-SiO₂ in Diabetic Nephropathy Rats via PTEN/AKT Pathway.
Guo J
J Nanosci Nanotechnol; 2021 Feb; 21(2):1079-1084. PubMed ID: 33183446
[TBL] [Abstract][Full Text] [Related]
42. The role of circular RNA in Diabetic Nephropathy.
Tu C; Wang L; Wei L; Jiang Z
Int J Med Sci; 2022; 19(5):916-923. PubMed ID: 35693742
[TBL] [Abstract][Full Text] [Related]
43. Interactions Among Non-Coding RNAs in Diabetic Nephropathy.
Loganathan TS; Sulaiman SA; Abdul Murad NA; Shah SA; Abdul Gafor AH; Jamal R; Abdullah N
Front Pharmacol; 2020; 11():191. PubMed ID: 32194418
[TBL] [Abstract][Full Text] [Related]
44. Targeting epigenetic regulators for treating diabetic nephropathy.
Kushwaha K; Garg SS; Gupta J
Biochimie; 2022 Nov; 202():146-158. PubMed ID: 35985560
[TBL] [Abstract][Full Text] [Related]
45. Exercise in Diabetic Nephropathy: Protective Effects and Molecular Mechanism.
Li RY; Guo L
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612417
[TBL] [Abstract][Full Text] [Related]
46. Rephrasing the 'David-Goliath' story in the field of diabetes.
Dey N
Mol Biol Rep; 2024 May; 51(1):672. PubMed ID: 38787502
[TBL] [Abstract][Full Text] [Related]
47. Deciphering the role of MicroRNAs in diabetic nephropathy: Regulatory mechanisms and molecular insights.
Abdelmaksoud NM; Al-Noshokaty TM; Abdelhamid R; Abdellatif N; Mansour A; Mohamed R; Mohamed AH; Khalil NAE; Abdelhamid SS; Mohsen A; Abdelaal H; Tawfik A; Elshaer SS
Pathol Res Pract; 2024 Apr; 256():155237. PubMed ID: 38492358
[TBL] [Abstract][Full Text] [Related]
48. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
[TBL] [Abstract][Full Text] [Related]
49. MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment.
Yarahmadi A; Shahrokhi SZ; Mostafavi-Pour Z; Azarpira N
Biochem Pharmacol; 2021 Jul; 189():114301. PubMed ID: 33203517
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
Dewanjee S; Bhattacharjee N
Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
[TBL] [Abstract][Full Text] [Related]
51. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
